CAL
IDXX icon

Capital Analysts LLC’s Idexx Laboratories IDXX Stock Holding History

Capital Analysts LLC’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed -$2K – 1338
2024
Q3 		$2K Hold
3
– – ﹤0.01% 1219
2024
Q2 		$1K Buy
+3
New +$1.51K ﹤0.01% 1155
2022
Q4 		– Sell
-4
Closed -$1K – 1109
2022
Q3 		$1K Buy
+4
New +$1.47K ﹤0.01% 1047
2022
Q1 		– Sell
-601
Closed -$396K – 982
2021
Q4 		$396K Sell
601
-15
-2% -$9.42K 0.02% 283
2021
Q3 		$383K Sell
616
-469
-43% -$315K 0.03% 281
2021
Q2 		$685K Hold
1,085
– – 0.05% 233
2021
Q1 		$531K Buy
1,085
+15
+1% +$7.51K 0.04% 248
2020
Q4 		$535K Buy
1,070
+20
+2% +$8.95K 0.05% 188
2020
Q3 		$413K Buy
1,050
+105
+11% +$38.8K 0.04% 208
2020
Q2 		$312K Sell
945
-65
-6% -$18.8K 0.03% 203
2020
Q1 		$245K Buy
+1,010
New +$264K 0.03% 193

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital Analysts LLC's IDXX Position: Q4 2024 in Review

Capital Analysts LLC sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 3 shares — an estimated $2K sold.

Capital Analysts LLC first reported a position in IDXX in Q1 2020 and held it in 11 quarters. The position peaked at $685K in Q2 2021. 1,125 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Capital Analysts LLC reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Capital Analysts LLC sold 3 Idexx Laboratories shares in Q4 2024, an estimated $2K.
  • Capital Analysts LLC first reported a position in Idexx Laboratories in Q1 2020 and held it in 11 quarters.
  • Capital Analysts LLC's Idexx Laboratories position peaked at $685K in Q2 2021.
  • 1,125 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Capital Analysts LLC's 13F filing for Q4 2024, filed 14 Feb 2025.